Curanex Pharmaceuticals CURX
NASDAQ CURX
$4.99 -0.02 (-0.40%)
As of: Oct 22, 2026 · 9:48 AM EDT

Curanex Pharmaceuticals (CURX) Liabilities and Shareholders Equity (2024 - 2026)

Updated

Curanex Pharmaceuticals (CURX) reported Liabilities and Shareholders Equity of $5.07 million for Q2 2026, up 544.6% from $787,174 a year earlier.

Analysis

Curanex Pharmaceuticals (CURX) Liabilities and Shareholders Equity (2024 - 2026) Analysis & Trends

At the end of FY2025, Curanex Pharmaceuticals posted Liabilities and Shareholders Equity of $11.58 million.

  • By year, Liabilities and Shareholders Equity came in at $517,935 in FY2024.
  • Five-year quarterly Liabilities and Shareholders Equity spans a low of $517,935 in Q4 2024 and a high of $14.48 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,162.99 Bn 1,131.58 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 633.71 Bn 552.23 Bn 17.26 Bn 201.06 Bn
3 AbbVie 502.40 Bn 475.51 Bn 12.70 Bn 135.12 Bn
4 Merck 376.48 Bn 330.86 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 303.61 Bn 267.60 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 267.02 Bn 240.70 Bn 12.86 Bn 115.83 Bn
7 Amgen 240.85 Bn 196.25 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 193.39 Bn 167.58 Bn 6.22 Bn 49.36 Bn
9 Pfizer 172.14 Bn 118.78 Bn 10.94 Bn 201.13 Bn
10 Curanex Pharmaceuticals 7.08 Mn -6.77 Mn - 5.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.07 Mn
Dec 31, 2025 11.58 Mn
Sep 30, 2025 14.48 Mn
Jun 30, 2025 787,174.00
Dec 31, 2024 517,935.00
API Access

Curanex Pharmaceuticals Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CURX&period=max&api_key=YOUR_API_KEY